Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.
about
From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized MedicinePharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study.Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.Pharmacometabonomics in humans: a new tool for personalized medicine.
P2860
Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Pharmacogenetics in cardiovasc ...... erence (CANNeCTIN), June 2009.
@en
Pharmacogenetics in cardiovasc ...... erence (CANNeCTIN), June 2009.
@nl
type
label
Pharmacogenetics in cardiovasc ...... erence (CANNeCTIN), June 2009.
@en
Pharmacogenetics in cardiovasc ...... erence (CANNeCTIN), June 2009.
@nl
prefLabel
Pharmacogenetics in cardiovasc ...... erence (CANNeCTIN), June 2009.
@en
Pharmacogenetics in cardiovasc ...... erence (CANNeCTIN), June 2009.
@nl
P2093
P2860
P356
P1433
P1476
Pharmacogenetics in cardiovasc ...... ference (CANNeCTIN), June 2009
@en
P2093
Philip G Joseph
Robert Roberts
Sonia S Anand
Stephanie Ross
P2860
P356
10.1002/CLC.22200
P577
2013-09-17T00:00:00Z